Form 4 for TCRX TScan Therapeutics, Inc.
Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-02 · accession 0000899243-23-014618 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-06 | 2023-06-02 | TCRX | BARBERICH TIMOTHY J | Dir | P - Purchase | $2.63 | +37.9K | 37.9K | New | +$99.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2023-06-02 | P | A | 37,880 | $2.63 | 37,880 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $2.60 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4. (F2) The Reporting Person's prior reports inadvertently included 33,259 shares of the Issuer's Voting Common Stock held by the Barberich Family Trust as directly owned by the Reporting Person. These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares. |